51-OR: a phase 2, randomized, double-blind, placebo-controlled, dose-finding study of bi 456906 in people with overweight/obesity
Le Roux C, Steen O, Lucas KJ, et al.
Diabetes. 2023;72(Supplement_1):51-OR.
Leggi
Le Roux C, Steen O, Lucas KJ, et al.
Diabetes. 2023;72(Supplement_1):51-OR.
Leggi
Sattar N, McMurray J, Borén J, et al.
Circulation. 2023;147:1872-1886
Leggi
Lingvay I, Asong M, Desouza C, et al.
JAMA. Pub. online 24 Jun 2023.
Leggi
Wharton S, Blevins T, Connery L, et al.
N Engl J Med. Pub. online 23 Jun 2023.
Leggi
Ritzel R, Ghosh S, Emral R, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2023.
Leggi
Collier A, Curran C, Cameron L, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2023.
Leggi
Liu X, Johnson SB, Lynch KF, et al.
Diabetes Care. 2023;46(7):1409-1416.
Leggi
Bea S, Choi A, Kim JH, et al.
Diabetes Obes Metab. Pub. online 13 Jun 2023.
Leggi
Li X, van Giessen A, Altunkaya J, et al.
Diabetes Care. 2023;46(7):1395-1403.
Leggi
Issaka A, Paradies Y, Cameron AJ, Stevenson C
NMCD. Pub. online 19 Jun 2023.
Leggi